engleski

Current Management and Novel Therapeutic Strategies to Combat Chronic Delta Hepatitis

HDV is an unusal, defective hepatotropic virus which causes severe acute hepatitis and most progressive chronic viral hepatitis. Despite the efforts in eradication of HDV, as its obligatory helper HBV, prevalence of HDV in developed countries remains stable and represents a relevant public health concern. Current conventional therapy of hepatitis delta is characterized with poor overall response, thus further investigations of novel treatment options are needed. Continuous research of virology and pathogenesis is necessary to provide fundamentals for development of novel approaches in treatment of HDV.

D virus infection ; polymerase chain reaction ; B surface antigen ; liver transplantation ; pegylated interferon-alpha-2B ; natural history ; peginterferon ; United States ; RNA ; replication

nije evidentirano